TORONTO – Labelling and packaging company CCL Industries Inc. (TSX:CCL.A) says it has acquired the pharmaceutical assets of an Australian printing company for $7.3 million.
The Toronto-based company said Tuesday it will take on the assets from privately owned Graphitype Printing Services.
The business it is taking over produces labels and instructional leaflets for pharmaceutical companies in Australia and will change the name of the business to CCL Label.
Get weekly money news
CCL says it will complement its existing health-care label operation in Melbourne.
Graphitype’s pharmaceutical division sales were A$7.3 million for the year ended June 30.
Steve Morris, the business leader of the Graphitype’s pharmaceutical division has signed on to join the healthcare and specialty group at CCL.
“The health-care sector continues to be attractive for us and we have been very successful with similar acquisitions in this product space in the recent past,” said Geoffrey Martin, president and CEO of CCL Industries.
- Alberta tweaks carbon capture incentive program to allow grants during construction
- ‘Cash is king’: Why money is a popular holiday present for many Canadians
- Rancher says Alberta well cleanup fund a positive step — but litany of concerns remain
- What makes the Anthropic IPO so significant, and what is the ‘god share’?
“The excellent facility in Sydney and the great team assembled by the Morris family while building the business will strengthen our position in Australia with sites now located in both of the key pharmaceutical manufacturing centres in the country.”
CCL Industries employs about 6,400 people and operates 72 production facilities around the world.
Comments
Want to discuss? Please read our Commenting Policy first.